MCID: ASP001
MIFTS: 49

Asperger Syndrome malady

Categories: Genetic diseases, Rare diseases, Mental diseases

Aliases & Classifications for Asperger Syndrome

About this section

Aliases & Descriptions for Asperger Syndrome:

Name: Asperger Syndrome 11 47 24 25 48 49 38 13 67
Asperger Disorder 47 24 25
Asperger's Syndrome 25 26
Asperger Syndrome Susceptibility, X-Linked 24
 
Asperger's Disorder 25
Asperger's Disease 25
Asperger Disease 25
Aspx1 24

Classifications:



External Ids:

Disease Ontology11 DOID:0050432
ICD1029 F84.5
MeSH38 D020817
NCIt44 C97159

Summaries for Asperger Syndrome

About this section
Genetics Home Reference:25 Asperger syndrome is a disorder on the autism spectrum, which is a group of conditions characterized by impaired communication and social interaction. Asperger syndrome is on the mild, or "high-functioning," end of the autism spectrum. Many affected individuals learn to compensate for their differences and live independent and successful lives. However, the behavioral challenges associated with this condition often lead to social isolation and difficulties at school, at work, and in personal relationships.

MalaCards based summary: Asperger Syndrome, also known as asperger disorder, is related to atypical autism and asperger syndrome susceptibility, x-linked 1. An important gene associated with Asperger Syndrome is NLGN4X (Neuroligin 4, X-Linked), and among its related pathways is Calcium signaling pathway. Affiliated tissues include testes, brain and eye, and related mouse phenotypes are behavior/neurological and nervous system.

Disease Ontology:11 An autism spectrum disorder that is characterized by significant difficulties in social interaction, along with restricted and repetitive patterns of behavior and interests. It differs from other autism spectrum disorders by its relative preservation of linguistic and cognitive development.

NINDS:48 Asperger syndrome (AS) is a developmental disorder.

Wikipedia:70 Asperger syndrome (AS), also known as Asperger\'s, is a developmental disorder characterized by... more...

Related Diseases for Asperger Syndrome

About this section

Diseases related to Asperger Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 55)
idRelated DiseaseScoreTop Affiliating Genes
1atypical autism28.7GABRB3, NLGN3, NLGN4X, OXTR, SLC25A12, SLC6A4
2asperger syndrome susceptibility, x-linked 112.3
3asperger syndrome susceptibility, x-linked 212.2
4autism spectrum disorder11.1
5autism susceptibility 1610.9
6autism 910.9
7autism susceptibility 1510.9
8autism 1010.9
9autism susceptibility 1710.9
10autism 1810.9
11autism susceptibility, x-linked 210.9
12autism x-linked 410.9
13autism susceptibility, x-linked 110.9
14autism susceptibility, x-linked 310.9
15autism x-linked 510.9
16epsilon-trimethyllysine hydroxylase deficiency10.9
17pervasive developmental disorder10.8
18paraphilia disorder10.3NLGN3, NLGN4X
19phlegmonous dacryocystitis10.2OXTR, SLC6A4
20anosognosia10.1OXTR, SLC6A4
21schizophrenia10.0
22learning disability10.0
23epileptic encephalopathy, early infantile, 269.9AVPR1A, AVPR1B
24hypoglycemic coma9.9DISC1, SLC6A4
25attention deficit-hyperactivity disorder9.8
26obsessive-compulsive disorder9.8
27personality disorder9.8
28prosopagnosia9.8
29anorexia nervosa9.8
30specific language impairment9.8
31gender identity disorder9.8
32conduct disorder9.8
33anxiety disorder9.8
34myotonic dystrophy9.8
35vernal conjunctivitis9.7DISC1, GABRB3, SHANK3, SLC6A4
36prader-willi syndrome9.7
37synesthesia9.6
38cystic fibrosis9.6
39common variable immunodeficiency9.6
40crohn's disease9.6
41temporal lobe epilepsy9.6
42writing disorder9.6
43alexithymia9.6
44stuttering9.6
45borderline personality disorder9.6
46epilepsy9.6
47psychotic disorder9.6
48astrocytoma9.6
49mood disorder9.6
50cerebritis9.6

Graphical network of the top 20 diseases related to Asperger Syndrome:



Diseases related to asperger syndrome

Symptoms for Asperger Syndrome

About this section

Drugs & Therapeutics for Asperger Syndrome

About this section

Drugs for Asperger Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 101)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DopamineapprovedPhase 4, Phase 3, Phase 2375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
2
MilnacipranapprovedPhase 45992623-85-365833
Synonyms:
( -)-Milnacipran
(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
(-)-milnacipran
(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl
105310-09-6
92623-85-3
AC1L2425
CHEMBL252923
CID65833
D08222
DB04896
F 2207
 
F-2207
F2207
Ixel
LS-178180
Midalcipran
Milnacipran
Milnacipran (INN)
Milnacipran [INN]
Milnacipranum
Milnacipranum [Latin]
Milnacipranum [latin]
NCGC00165825-01
Toledomin
UNII-G56VK1HF36
milnacipran
3
Methylphenidateapproved, investigationalPhase 4373113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
 
Methyl phenidyl acetate
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
4
Risperidoneapproved, investigationalPhase 4, Phase 3487106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
 
NCGC00015883-01
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
5
Guanfacineapproved, investigationalPhase 45629110-47-23519
Synonyms:
29110-47-2
29110-48-3 (mono-hydrochloride)
AC1L1G4B
BPBio1_000415
BRD-K32830106-003-03-0
BSPBio_000377
C07037
C9H9Cl2N3O
CAS-29110-48-3
CHEMBL862
CID3519
D08031
DB01018
EINECS 249-442-8
Estulic
Estulic (TN)
G1043_SIGMA
GUANFACINE
Guanfacina
Guanfacina [INN-Spanish]
Guanfacine (INN)
Guanfacine Monohydrochloride
Guanfacine [INN:BAN]
Guanfacinum
 
Guanfacinum [INN-Latin]
Intuniv
L000286
L013430
LS-174236
Lon798
Lopac-G-1043
Lopac0_000519
MolPort-003-941-447
N (Aminoiminomethyl)-2,6-dichlorobenzeneacetamide
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide
NCGC00015469-01
NCGC00015469-02
NCGC00015469-06
NCGC00024950-01
NCGC00024950-02
NCGC00024950-03
Prestwick0_000339
Prestwick1_000339
Prestwick2_000339
Prestwick3_000339
SPBio_002298
SPD 503
Tocris-1030
UNII-30OMY4G3MK
ZINC03872738
6
Creatineapproved, nutraceuticalPhase 412657-00-1586
Synonyms:
((amino(Imino)methyl)(methyl)amino)acetic acid
((amino(imino)methyl)(methyl)amino)acetate
((amino(imino)methyl)(methyl)amino)acetic acid
(N-methylcarbamimidamido)acetic acid
(alpha-Methylguanido)acetate
(alpha-Methylguanido)acetic acid
(α-methylguanido)acetic acid
Cosmocair C 100
Creatin
Creatine
Creatine hydrate
Kreatin
 
Krebiozon
Methylglycocyamine
Methylguanidoacetate
Methylguanidoacetic acid
N-(Aminoiminomethyl)-N-Methyl-Glycine
N-(aminoiminomethyl)-N-methylglycine
N-Amidinosarcosine
N-Carbamimidoyl-N-methylglycine
N-Methyl-N-guanylglycine
N-[(e)-AMINO(imino)methyl]-N-methylglycine
Phosphagen
[[Amino(imino)methyl](methyl)amino]acetate
[[Amino(imino)methyl](methyl)amino]acetic acid
alpha-Methylguanidino acetic acid
7
Cholineapproved, nutraceuticalPhase 414862-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
8Neurotransmitter AgentsPhase 4, Phase 3, Phase 217734
9Dopamine AgentsPhase 4, Phase 3, Phase 23759
10Atomoxetine HydrochloridePhase 4, Phase 3168
11Neurotransmitter Uptake InhibitorsPhase 4, Phase 3, Phase 23464
12Adrenergic AgonistsPhase 42877
13Adrenergic alpha-AgonistsPhase 41625
14Antihypertensive AgentsPhase 44095
15Antipsychotic AgentsPhase 4, Phase 3, Phase 22359
16Adrenergic alpha-2 Receptor AgonistsPhase 4911
17Serotonin Uptake InhibitorsPhase 4, Phase 21570
18Psychotropic DrugsPhase 4, Phase 3, Phase 26279
19
PhosphocreatinePhase 4667-07-2587
Synonyms:
Creatine phosphate
Creatine-P
Creatine-phosphate
Creatinephosphoric acid
N-(Phosphonoamidino)-Sarcosine
N-(Phosphonoamidino)sarcosine
 
N-Phosphocreatine
N-Phosphorocreatine
N-Phosphorylcreatine
N-[Imino(phosphonoamino)methyl]-N-methyl-Glycine
Neo-ton
P-Creatine
Phosphocreatine
Phosphorylcreatine
20Dopamine AntagonistsPhase 4, Phase 3, Phase 21083
21Antidepressive AgentsPhase 4, Phase 3, Phase 22666
22
SerotoninPhase 4, Phase 3, Phase 2356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
23Serotonin AgentsPhase 4, Phase 3, Phase 23102
24Adrenergic AgentsPhase 4, Phase 3, Phase 25140
25Central Nervous System DepressantsPhase 4, Phase 3, Phase 212806
26Tranquilizing AgentsPhase 4, Phase 3, Phase 24164
27Serotonin AntagonistsPhase 4, Phase 3, Phase 21381
28Dopamine Uptake InhibitorsPhase 41305
29Central Nervous System StimulantsPhase 42132
30AntibodiesPhase 46045
31Immunoglobulins, IntravenousPhase 4324
32Rho(D) Immune GlobulinPhase 4317
33gamma-GlobulinsPhase 4317
34ImmunoglobulinsPhase 46045
35
CycloserineapprovedPhase 310668-41-7401, 6234
Synonyms:
(+)-4-Amino-3-isoxazolidinone
(+)-Cycloserine
(4R)-4-Amino-3-isoxazolidinone
(4R)-4-amino-1,2-oxazolidin-3-one
(4R)-4-aminoisoxazolidin-3-one
(R)-(+)-4-Amino-3-isoxazolidinone
(R)-(+)-Cycloserine
(R)-4-AMINO-ISOXAZOLIDIN-3-ONE
(R)-4-AMINO-isoxazolidin-3-one
(R)-4-Amino-3-isoxazolidinone
(R)-4-Amino-3-isoxazolidone
(R)-Cycloserine
1pb9
3-Isoxazolidinone, 4-amino-, (+)- (8CI)
3-Isoxazolidinone, 4-amino-, (4R)- (9CI)
3-Isoxazolidinone, 4-amino-, (R)
3-Isoxazolidinone, 4-amino-, D
30020_FLUKA
30020_SIGMA
4-27-00-05549 (Beilstein Handbook Reference)
4AX
68-41-7
AB00443920
AC-4721
AC1L1M33
AC1Q4UA7
AI3-50153
BB_NC-1631
BIDD:GT0707
BPBio1_001252
BRN 0080798
BSPBio_001138
BSPBio_002121
C 3909
C-9390
C-9400
C08057
C3909_SIGMA
C3H6N2O2
C6880_SIGMA
C7670_SIGMA
CAS-339-72-0
CAS-68-41-7
CHEBI:40009
CHEMBL771
CID6234
CPD-2482
CPD000058313
Cicloserina
Cicloserina [INN-Spanish]
Cicloserina [Italian]
Closerin
Closina
Cyclo-D-serine
Cyclorin
Cycloserine
Cycloserine (JP15/USP/INN)
Cycloserine [INN:BAN:JAN]
Cycloserinum
Cycloserinum [INN-Latin]
D-(+)-Cycloserine
D-4-Amino-3-isossazolidone
D-4-Amino-3-isossazolidone [Italian]
D-4-amino-3-Isoxazolidinone
D-4-amino-3-Isoxazolidone
D-4-amino-3-isoxazolidinone
D-4-amino-3-isoxazolidone
D-CS
D-Cycloserine
D-Cycloserine synth. BP 88
D-Cycloserine, synthetic
D-Oxamicina
D-Oxamycin
D-amino-3-isoxazolidinone
D-cycloserine
D00877
DB03123
DCS
DL-Cycloserine
DRG-0195
DivK1c_000098
E-733-A
EINECS 200-688-4
 
EU-0100252
FA6C7F8B-D080-4EA3-978F-1ECFB5A29D09
Farmiserina
HMS1571I20
HMS1920C06
HMS2051C15
HMS2091I14
HMS500E20
HSDB 3218
I-1431
IDI1_000098
K-300
KBio1_000098
KBio2_001340
KBio2_003908
KBio2_006476
KBio3_001341
KBioGR_000890
KBioSS_001340
L-Cycloserine
LMPK14000007
LS-86757
Lopac-C-1159
Lopac-C-3909
Lopac-C-7005
Lopac0_000252
MLS000758215
MLS001423962
Micoserina
Miroserina
Miroseryn
MolPort-000-858-643
NCGC00015213-01
NCGC00015213-02
NCGC00015213-03
NCGC00016306-01
NCGC00016306-02
NCGC00016306-03
NCGC00016306-05
NCGC00093713-01
NCGC00093713-02
NINDS_000098
NSC 154851
Novoserin
Orientomycin
Oxamicina
Oxamicina [Italian]
Oxamycin
PA 94
PA-94
Prestwick0_001089
Prestwick1_001089
Prestwick2_001089
Prestwick3_001089
R(+)-4-Amino-3-isoxazolidinone
R-(+)-Cycloserine
R-4-Amino-3-isoxazolidinone
RO-1-9213
Ro-1-9213
S1998_Selleck
SAM001247014
SAM002264599
SC-49088
SMP1_000167
SMR000058313
SPBio_000008
SPBio_003029
SPECTRUM1500215
Seromycin
Seromycin (TN)
Spectrum2_000084
Spectrum3_000371
Spectrum4_000305
Spectrum5_000797
Spectrum_000860
Tebemicina
Tisomycin
UNII-95IK5KI84Z
Wasserina
alpha-Cycloserine
cyclo-D-Serine
cycloserine
orientomycin
α-Cycloserine
36
HistamineapprovedPhase 3103475614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
5-Imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
37
Histamine PhosphateapprovedPhase 3103351-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
Histaminum
LS-78569
UNII-QWB37T4WZZ
38
MianserinapprovedPhase 35124219-97-44184
Synonyms:
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
21535-47-7 (mono-hydrochloride)
24219-97-4
AC-631
AC1L1HLP
BPBio1_000064
BPBio1_000331
BRD-A19661776-001-01-5
BRD-A19661776-003-05-2
BRN 0755346
BSPBio_000058
BSPBio_003511
Biomol-NT_000135
Bolvidon
C18H20N2
CHEBI:51137
CHEMBL6437
CID4184
D08216
DB06148
DivK1c_000844
EINECS 246-088-6
HMS2089A04
HSDB 7182
IDI1_000844
KBio1_000844
KBio2_002301
KBio2_004869
KBio2_007437
KBio3_003016
KBioGR_001820
KBioSS_002303
L000736
LS-61197
Lopac0_000744
 
Mianserin (INN)
Mianserin Monohydrochloride
Mianserin [INN:BAN]
Mianserina
Mianserina [INN-Spanish]
Mianserina [inn-spanish]
Mianserine
Mianserine [INN-French]
Mianserine [inn-french]
Mianserinum
Mianserinum [INN-Latin]
Mianserinum [inn-latin]
Mianseryna
Mianseryna [Polish]
Mianseryna [polish]
MolPort-003-849-215
NCGC00015656-09
NCGC00024926-03
NCGC00024926-04
NINDS_000844
Norval
Oprea1_703627
PDSP1_001532
PDSP2_001516
Prestwick0_000099
Prestwick1_000099
Prestwick2_000099
Prestwick3_000099
SPBio_000986
SPBio_001997
Spectrum2_001203
Spectrum3_001836
Spectrum4_001260
Spectrum5_001772
Spectrum_001810
Tolvan
Tolvon
Tolvon (TN)
mianserin
39
ZiprasidoneapprovedPhase 3145146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
40
MirtazapineapprovedPhase 38985650-52-8, 61337-67-54205
Synonyms:
(1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine
(N-methyl-11C)mirtazapine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine
5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
6-Azamianserin
61337-67-5
82601-27-2
85650-52-8
AC-15480
AC1L1HND
AC1Q3ZYM
Avanza
Axit
Azamianserin
BRD-A64977602-001-01-9
C035133
C07570
CHEBI:6950
CHEMBL654
CID4205
CPD000466347
Celltech brand of mirtazapine
D00563
DB00370
EINECS 288-060-6
HMS2052H03
I01-1882
I06-0606
L001294
LS-127703
LS-185067
M0443_SIGMA
ME-2040
MLS000759460
MLS001076676
Mepirzapin
 
Mepirzapine
Mepirzepine
Mirtabene
Mirtaz
Mirtazapin
Mirtazapina
Mirtazapina [INN-Spanish]
Mirtazapine
Mirtazapine (JAN/USAN/INN)
Mirtazapine [USAN:BAN:INN]
Mirtazapine [USAN:INN:BAN]
Mirtazapine [Usan:Ban:Inn]
Mirtazapinum
Mirtazapinum [INN-Latin]
Mirtazepine
Mirtazipine
Mirtazon
MolPort-003-849-233
Mundogen brand of mirtazapine
NCGC00025346-02
Norset
ORG 3770
Org-3770
Organon brand of mirtazapine
PDSP1_001529
PDSP2_001513
Promyrtil
Remergil
Remergon
Remeron
Remeron (TN)
Remeron SolTab
Remeron Soltab
Rexer
SAM001246659
SMR000466347
STK711107
UNII-A051Q2099Q
Zispin
mirtazapine
41Anti-Bacterial AgentsPhase 310884
42Antibiotics, AntitubercularPhase 36972
43AntimetabolitesPhase 311774
44Antitubercular AgentsPhase 31272
45Renal AgentsPhase 3732
46Adrenergic alpha-AntagonistsPhase 3, Phase 2727
47Adrenergic AntagonistsPhase 3, Phase 21535
48Antidepressive Agents, Second-GenerationPhase 3, Phase 21287
49Anti-Infective AgentsPhase 3, Phase 221402
50Histamine H1 AntagonistsPhase 3782

Interventional clinical trials:

(show top 50)    (show all 79)
idNameStatusNCT IDPhase
1Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone StudyCompletedNCT00352196Phase 4
2Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of AutismCompletedNCT01337700Phase 4
3Atomoxetine, Placebo and Parent Management Training in AutismCompletedNCT00844753Phase 4
4Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental DisorderCompletedNCT01238575Phase 4
5Understanding the Effects of Intervention on the Brain in AutismRecruitingNCT02680015Phase 4
6Methylphenidate ER Liquid Formulation in Adults With ASD and ADHDRecruitingNCT02096952Phase 4
7An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism SpectrumActive, not recruitingNCT02199925Phase 4
8Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With AutismCompletedNCT00498173Phase 3
9D-Cycloserine and Social Skills Training in Autism Spectrum DisordersCompletedNCT01086475Phase 3
10Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01178385Phase 2, Phase 3
11A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)CompletedNCT00261508Phase 3
12Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental DisordersRecruitingNCT01302964Phase 3
13Psychotherapy for Anxiety in Children With Autism Spectrum DisorderRecruitingNCT02028247Phase 3
14Deep rTMS (Repetitive Transcranial Magnetic Stimulation)for Treatment of Autism Symptoms in Children.Unknown statusNCT01388179Phase 2
15An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)CompletedNCT01592786Phase 2
16Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With MemantineCompletedNCT01592747Phase 2
17CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOSCompletedNCT00280670Phase 2
18The Development of Autistic Children Based on Mothers´Response in Autism Behavior ChecklistCompletedNCT00725556Phase 1, Phase 2
19Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for AdolescentsCompletedNCT01177969Phase 1, Phase 2
20A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.CompletedNCT00198055Phase 2
21A Study of Oral N-Acetylcysteine in Children With Autism Spectrum DisordersCompletedNCT00453180Phase 2
22Study of Aripiprazole to Treat Children and Adolescents With AutismCompletedNCT00619190Phase 2
23Cholesterol in ASD: Characterization and TreatmentCompletedNCT00965068Phase 1, Phase 2
24An Open-Label Trial of Aripiprazole in Autism Spectrum DisordersCompletedNCT00308074Phase 2
25Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)CompletedNCT01248728Phase 2
26Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum DisordersCompletedNCT01288716Phase 2
27My Scrivener® - Measuring Effectiveness and Dose Response in ChildrenCompletedNCT00919906Phase 1, Phase 2
28Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2
29Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2
30Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)CompletedNCT00086645Phase 2
31Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)TerminatedNCT01592773Phase 2
32Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in AutismTerminatedNCT01983189Phase 2
33A Folinic Acid Intervention for Autism Spectrum DisordersTerminatedNCT01602016Phase 2
34Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
35Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and AnxietyCompletedNCT01187784Phase 1
36Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQUnknown statusNCT00505830
37Portable Visual Guidance System Phase IIUnknown statusNCT00848874
38Memantine in Adult Autism Spectrum DisorderUnknown statusNCT01078844
39Adolescent Social Skills Training ProgramUnknown statusNCT01031823
40Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum DisorderUnknown statusNCT01631851
41Phenotypic and Genetic Factors in Autism Spectrum DisordersUnknown statusNCT00910559
42A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's SyndromeCompletedNCT01669889
43The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's DisorderCompletedNCT00808782
44Validation of the French Adaptation of the RAADS-R Scale : Scale of Asperger Syndrome DiagnosisCompletedNCT02826148
45Psychometric Studies of the Chinese Versions of the SRS, CAST, and AQCompletedNCT01247662
46Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in AutismCompletedNCT00211783
47Cognitive Behavioural Therapy (CBT) and Recreational Activity for Autism Spectrum Disorders (ASD)CompletedNCT01655173
48Advanced Grandparental Age as a Risk Factor for AutismCompletedNCT00464477
49Predictors of Caregiver Adaptation to Pervasive Developmental DisordersCompletedNCT00496210
50RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental DisordersCompletedNCT00080145

Search NIH Clinical Center for Asperger Syndrome


Cochrane evidence based reviews: asperger syndrome

Genetic Tests for Asperger Syndrome

About this section

Genetic tests related to Asperger Syndrome:

id Genetic test Affiliating Genes
1 Asperger's Disorder26
2 Asperger Disorder24

Anatomical Context for Asperger Syndrome

About this section

MalaCards organs/tissues related to Asperger Syndrome:

35
Testes, Brain, Eye, Amygdala, Temporal lobe, Skin, Cortex

Animal Models for Asperger Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Asperger Syndrome:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053867.0AVPR1A, AVPR1B, CYP11B1, DISC1, GABRB3, NLGN3
2MP:00036316.3ARNT2, AVPR1A, AVPR1B, DISC1, GABRB3, NLGN3

Publications for Asperger Syndrome

About this section

Articles related to Asperger Syndrome:

(show top 50)    (show all 471)
idTitleAuthorsYear
1
Romantic Relationships and Relationship Satisfaction Among Adults With Asperger Syndrome and High-Functioning Autism. (27196958)
2016
2
A Concise History of Asperger Syndrome: The Short Reign of a Troublesome Diagnosis. (26834663)
2015
3
I Collect Therefore I am-Autonoetic Consciousness and Hoarding in Asperger Syndrome. (24615808)
2014
4
The neuropsychology of male adults with high-functioning autism or asperger syndrome. (24903974)
2014
5
Neurological abnormalities in recent-onset schizophrenia and asperger-syndrome. (25147527)
2014
6
Gaze and visual search strategies of children with Asperger syndrome/high functioning autism viewing a magic trick. (24866104)
2014
7
Automatic metaphor processing in adults with Asperger syndrome: a metaphor interference effect task. (24081827)
2013
8
Asperger syndrome in young adulthood: the physician as supportive coach and medical advisor. (24654553)
2013
9
Asperger syndrome and "non-verbal learning problems" in a longitudinal perspective: neuropsychological and social adaptive outcome in early adult life. (23871410)
2013
10
Integrating intention and context: assessing social cognition in adults with Asperger syndrome. (23162450)
2012
11
Autobiographical accounts of sensing in Asperger syndrome and high-functioning autism. (22999038)
2012
12
Effects of video modeling on communicative social skills of college students with Asperger syndrome. (23030681)
2012
13
Anatomy and aging of the amygdala and hippocampus in autism spectrum disorder: an in vivo magnetic resonance imaging study of Asperger syndrome. (21948742)
2012
14
Referral pattern and special interests in children and adolescents with Asperger syndrome: a Turkish referred sample. (22987894)
2012
15
Support to students with Asperger syndrome in higher education--the perspectives of three relatives and three coordinators. (22315142)
2012
16
Mosaic partial trisomy 19p12-q13.11 due to a small supernumerary marker chromosome: a locus associated with Asperger syndrome? (21815264)
2011
17
Reflections on Asperger syndrome and comorbidity with psychotic disorders. (21404153)
2011
18
White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults. (20625995)
2010
19
Absence of a normal cortisol awakening response (CAR) in adolescent males with Asperger syndrome (AS). (19304400)
2009
20
Differentiating autism and Asperger syndrome on the basis of language delay or impairment. (17721697)
2008
21
Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). (17990089)
2008
22
Association of DISC1 with autism and Asperger syndrome. (17579608)
2008
23
Disembedding performance in children and adolescents with Asperger syndrome or high-functioning autism. (17175576)
2007
24
Answering contextually demanding questions: pragmatic errors produced by children with Asperger syndrome or high-functioning autism. (17126362)
2007
25
Autobiographical memory and social problem-solving in Asperger syndrome. (16874561)
2007
26
Brief report: social and communication abilities and disabilities in higher functioning individuals with autism and Asperger syndrome. (17160458)
2007
27
Effects of vagus nerve stimulation in a patient with temporal lobe epilepsy and Asperger syndrome: case report and review of the literature. (17300990)
2007
28
Independent replication and initial fine mapping of 3p21-24 in Asperger syndrome. (16467216)
2006
29
Diagnosis of Asperger syndrome in a 66-year-old male presenting with depression. (16734928)
2006
30
Understanding and negotiating friendships: perspectives from an adolescent with Asperger syndrome. (17088277)
2006
31
Finding a face in the crowd: testing the anger superiority effect in Asperger Syndrome. (16455174)
2006
32
Is Asperger syndrome associated with abnormal nocturnal motor phenomena? (16884459)
2006
33
The quality of life of young men with Asperger syndrome: a brief report. (16908482)
2006
34
Verbal marking of affect by children with Asperger Syndrome and high functioning autism during spontaneous interactions with family members. (16897388)
2006
35
An experimental investigation of the phenomenology of delusional beliefs in people with Asperger syndrome. (16287703)
2005
36
Behavioural aspects of cerebellar function in adults with Asperger syndrome. (16321884)
2005
37
Asperger syndrome. (15909411)
2005
38
Asperger Syndrome, obsessive-compulsive disorder, and major depression in a patient with 45,X/46,XY mosaicism. (15153741)
2004
39
Outcome research in Asperger syndrome and autism. (12512398)
2003
40
Psychosocial functioning in a group of Swedish adults with Asperger syndrome or high-functioning autism. (12638767)
2003
41
Misdiagnosis of Asperger syndrome as anankastic personality disorder. (12540134)
2002
42
Asperger syndrome: tests of right hemisphere functioning and interhemispheric communication. (12199132)
2002
43
'Can I join the club?': a social integration scheme for adolescents with Asperger syndrome. (12540132)
2002
44
Recognition of faux pas by normally developing children and children with Asperger syndrome or high-functioning autism. (10587887)
1999
45
A test of central coherence theory: linguistic processing in high-functioning adults with autism or Asperger syndrome: is local coherence impaired? (10444907)
1999
46
A screening questionnaire for Asperger syndrome and other high-functioning autism spectrum disorders in school age children. (10382133)
1999
47
The diagnosis of autism and Asperger syndrome: findings from a survey of 770 families. (10619282)
1999
48
A comparative study of Asperger syndrome with high-functioning atypical autism. (9141143)
1997
49
Validity and neuropsychological characterization of Asperger syndrome: convergence with nonverbal learning disabilities syndrome. (8847376)
1995
50
Asperger syndrome--some epidemiological considerations: a research note. (2670981)
1989

Variations for Asperger Syndrome

About this section

Expression for genes affiliated with Asperger Syndrome

About this section
Search GEO for disease gene expression data for Asperger Syndrome.

Pathways for genes affiliated with Asperger Syndrome

About this section

Pathways related to Asperger Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.2AVPR1A, AVPR1B, OXTR

GO Terms for genes affiliated with Asperger Syndrome

About this section

Cellular components related to Asperger Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1excitatory synapseGO:006007610.4NLGN3, NLGN4X
2postsynaptic densityGO:00140699.5DISC1, NLGN4X, SHANK3
3postsynaptic membraneGO:00452119.3DISC1, GABRB3, NLGN4X, SHANK3
4cell junctionGO:00300549.0DISC1, GABRB3, NLGN3, NLGN4X, SHANK3
5integral component of plasma membraneGO:00058877.5AVPR1A, AVPR1B, GABRB3, NLGN3, NLGN4X, OXTR

Biological processes related to Asperger Syndrome according to GeneCards Suite gene sharing:

(show all 29)
idNameGO IDScoreTop Affiliating Genes
1presynaptic membrane assemblyGO:009710510.6NLGN3, NLGN4X
2regulation of long-term synaptic potentiationGO:190027110.5NLGN3, SHANK3
3positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activityGO:200096910.5NLGN3, SHANK3
4negative regulation of excitatory postsynaptic potentialGO:009039410.5NLGN3, NLGN4X
5neuron cell-cell adhesionGO:000715810.4NLGN3, NLGN4X
6positive regulation of dendritic spine developmentGO:006099910.4NLGN3, SHANK3
7brain morphogenesisGO:004885410.3SHANK3, SLC6A4
8positive regulation of excitatory postsynaptic potentialGO:200046310.3NLGN3, SHANK3
9regulation of dendritic spine morphogenesisGO:006100110.3NLGN3, SHANK3
10inhibitory postsynaptic potentialGO:006008010.2GABRB3, NLGN3
11telencephalon developmentGO:002153710.2AVPR1A, OXTR
12long-term synaptic potentiationGO:006029110.1NLGN3, SHANK3
13positive regulation of blood pressureGO:004577710.1AVPR1A, OXTR
14activation of phospholipase C activityGO:000720210.1AVPR1A, AVPR1B
15vocalization behaviorGO:007162510.0NLGN3, NLGN4X, SHANK3
16synapse organizationGO:005080810.0NLGN3, NLGN4X
17sperm ejaculationGO:004271310.0AVPR1A, OXTR, SLC6A4
18positive regulation of synaptic transmission, glutamatergicGO:00519689.8NLGN3, OXTR, SHANK3
19response to peptideGO:19016529.8AVPR1A, AVPR1B, OXTR
20memoryGO:00076139.7OXTR, SHANK3, SLC6A4
21maternal behaviorGO:00427119.7AVPR1A, OXTR
22response to estradiolGO:00323559.7ARNT2, OXTR, SLC6A4
23positive regulation of vasoconstrictionGO:00459079.6AVPR1A, AVPR1B, OXTR
24adult behaviorGO:00305349.6NLGN3, NLGN4X, SHANK3
25positive regulation of cytosolic calcium ion concentrationGO:00072049.6AVPR1A, AVPR1B, OXTR
26regulation of systemic arterial blood pressure by vasopressinGO:00019929.5AVPR1A, AVPR1B, OXTR
27learningGO:00076129.4NLGN3, NLGN4X, SHANK3
28cellular response to hormone stimulusGO:00328709.1AVPR1A, AVPR1B, CYP11B1, OXTR
29social behaviorGO:00351768.6AVPR1A, NLGN3, NLGN4X, OXTR, SHANK3, SLC6A4

Molecular functions related to Asperger Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1carboxylic ester hydrolase activityGO:005268910.3NLGN3, NLGN4X
2neurexin family protein bindingGO:004204310.2NLGN3, NLGN4X
3peptide hormone bindingGO:001704610.1AVPR1A, OXTR
4scaffold protein bindingGO:00971109.7NLGN3, NLGN4X, SHANK3
5vasopressin receptor activityGO:00050009.6AVPR1A, AVPR1B, OXTR
6peptide bindingGO:00422779.1AVPR1A, AVPR1B, OXTR

Sources for Asperger Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet